Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
- PMID: 17625570
- DOI: 10.1038/nature05945
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Abstract
Improvement in the clinical outcome of lung cancer is likely to be achieved by identification of the molecular events that underlie its pathogenesis. Here we show that a small inversion within chromosome 2p results in the formation of a fusion gene comprising portions of the echinoderm microtubule-associated protein-like 4 (EML4) gene and the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer (NSCLC) cells. Mouse 3T3 fibroblasts forced to express this human fusion tyrosine kinase generated transformed foci in culture and subcutaneous tumours in nude mice. The EML4-ALK fusion transcript was detected in 6.7% (5 out of 75) of NSCLC patients examined; these individuals were distinct from those harbouring mutations in the epidermal growth factor receptor gene. Our data demonstrate that a subset of NSCLC patients may express a transforming fusion kinase that is a promising candidate for a therapeutic target as well as for a diagnostic molecular marker in NSCLC.
Comment in
-
Cancer: broken genes in solid tumours.Nature. 2007 Aug 2;448(7153):545-6. doi: 10.1038/448545a. Nature. 2007. PMID: 17671492 No abstract available.
Similar articles
-
EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers.J Thorac Oncol. 2008 Jan;3(1):13-7. doi: 10.1097/JTO.0b013e31815e8b60. J Thorac Oncol. 2008. PMID: 18166835
-
Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs.Cell Mol Life Sci. 2016 Mar;73(6):1209-24. doi: 10.1007/s00018-015-2117-6. Epub 2016 Jan 11. Cell Mol Life Sci. 2016. PMID: 26755435 Free PMC article. Review.
-
Cancer: broken genes in solid tumours.Nature. 2007 Aug 2;448(7153):545-6. doi: 10.1038/448545a. Nature. 2007. PMID: 17671492 No abstract available.
-
Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing.Arch Pathol Lab Med. 2012 Jul;136(7):796-803. doi: 10.5858/arpa.2011-0321-OA. Arch Pathol Lab Med. 2012. PMID: 22742552
-
ALK inhibitors in the treatment of advanced NSCLC.Cancer Treat Rev. 2014 Mar;40(2):300-6. doi: 10.1016/j.ctrv.2013.07.002. Epub 2013 Aug 7. Cancer Treat Rev. 2014. PMID: 23931927 Review.
Cited by
-
Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy.Pharmacogenomics. 2013 Feb;14(3):315-24. doi: 10.2217/pgs.12.213. Pharmacogenomics. 2013. PMID: 23394393 Free PMC article. Review.
-
Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes.Nat Commun. 2014 Dec 22;5:5893. doi: 10.1038/ncomms6893. Nat Commun. 2014. PMID: 25531467 Free PMC article.
-
Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors.JCO Precis Oncol. 2021 May 3;5:PO.20.00383. doi: 10.1200/PO.20.00383. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34036223 Free PMC article.
-
Mouse model for ROS1-rearranged lung cancer.PLoS One. 2013;8(2):e56010. doi: 10.1371/journal.pone.0056010. Epub 2013 Feb 13. PLoS One. 2013. PMID: 23418494 Free PMC article.
-
Treating ALK-positive lung cancer--early successes and future challenges.Nat Rev Clin Oncol. 2012 Apr 3;9(5):268-77. doi: 10.1038/nrclinonc.2012.43. Nat Rev Clin Oncol. 2012. PMID: 22473102 Free PMC article. Review.
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous